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What\'s new?This is the first synthesis to determine the direction of association between anxiety and diabetes.The results indicate that anxiety is a risk factor for incident diabetes.The results also indicate that there is a need for further research into diabetes as a risk factor for incident anxiety.

Introduction {#dme13606-sec-0006}
============

The prevalence of diabetes is increasing, with current estimates projecting that 642 million people worldwide will have diabetes by 2040 [1](#dme13606-bib-0001){ref-type="ref"}. As the prevalence of diabetes increases there is interest in identifying modifiable diabetes risk factors that could be targeted by interventions to reduce this projected increase. Alongside this, there is also interest in reducing the burden of diabetes in people who already have the condition by identifying modifiable risk factors associated with poorer health outcomes. Poor mental health has been identified as a potentially modifiable risk factor associated with an increased risk of both developing diabetes and poorer outcomes in people who have diabetes [2](#dme13606-bib-0002){ref-type="ref"}, [3](#dme13606-bib-0003){ref-type="ref"}. Therefore, there is interest in how mental illness and diabetes are linked.

Anxiety disorders are a group of mental disorders characterized by feelings of anxiety and fear that significantly impact the social and occupational functioning of individuals [4](#dme13606-bib-0004){ref-type="ref"}. They are among some of the most prevalent mental disorders in the population, affecting up to 30% of adults [5](#dme13606-bib-0005){ref-type="ref"}, [6](#dme13606-bib-0006){ref-type="ref"}. Furthermore, anxiety disorders are one of the leading causes of disability worldwide [7](#dme13606-bib-0007){ref-type="ref"} and are associated with a poorer quality of life [8](#dme13606-bib-0008){ref-type="ref"}. Alongside their immediate impact on mental health and functioning, there is also evidence that symptoms of anxiety and anxiety disorders might be associated with an increased risk of developing non‐communicable diseases such as heart disease [9](#dme13606-bib-0009){ref-type="ref"}. It is possible that anxiety could lead to diabetes as it shares strong associations with many of the acknowledged risk factors for diabetes such as overweight/obesity [10](#dme13606-bib-0010){ref-type="ref"}, cardiometabolic abnormalities [11](#dme13606-bib-0011){ref-type="ref"}, unhealthy lifestyle behaviours [12](#dme13606-bib-0012){ref-type="ref"} and sleep disturbance [13](#dme13606-bib-0013){ref-type="ref"}. However, data on anxiety as a risk factor for incident diabetes has not yet been synthesized, so it is unclear whether anxiety itself is an independent risk factor for the development of diabetes.

Previous research indicates that people with diabetes have a greater likelihood of developing mental health problems such as depression [14](#dme13606-bib-0014){ref-type="ref"}. It is possible that biological changes induced by diabetes [15](#dme13606-bib-0015){ref-type="ref"} alongside lifestyle limitations and feelings related to living with a serious chronic illness [16](#dme13606-bib-0016){ref-type="ref"} could all be linked with poorer mental health. However, there is no synthesis that tells us whether diabetes might be linked with a greater risk of developing anxiety. Previous meta‐analyses and systematic reviews indicate that people with diabetes have an increased likelihood of concurrent anxiety [17](#dme13606-bib-0017){ref-type="ref"}, [18](#dme13606-bib-0018){ref-type="ref"}, however we do not know if diabetes is associated with an increased risk of developing incident anxiety.

The aim of this review was to determine the longitudinal association between diabetes and anxiety by systematically searching for and reviewing studies that investigated either anxiety as a risk factor for incident diabetes in adults aged 16 or older or diabetes as a risk factor for incident anxiety in adults aged 16 or older.

Methods {#dme13606-sec-0007}
=======

Search strategy {#dme13606-sec-0008}
---------------

A systematic literature search was conducted by KS and SD between January 2017 and August 2017. The study protocol was registered on PROSPERO (protocol ID: CRD42017056775; <https://www.crd.york.ac.uk/PROSPERO>). There were no restrictions on publication date or language, although only English and French language studies were reviewed. Search terms relating to synonyms of 'anxiety' and 'diabetes' (see Doc. [S1](#dme13606-sup-0006){ref-type="supplementary-material"}) were searched in seven databases including PubMed (United States National Library of Medicine, Bethesda, MD, USA), SCOPUS (Elsevier, Amsterdam, Netherlands), EMBASE (Elsevier), ISI Web of Knowledge (Thomson Reuters, New York, NY, USA), PsychINFO (American Psychological Association, Washington DC, USA), CINAHL (Elsevier) and ProQuest (Dissertations and Theses; conference papers index and Nursing and Allied Health) (ProQuest, Ann Arbour, MI, USA).

Further to this, hand searches were undertaken within relevant conference proceedings and journals (see Supporting Information Doc. [S1](#dme13606-sup-0006){ref-type="supplementary-material"}). The bibliographies of relevant reviews on anxiety and diabetes [17](#dme13606-bib-0017){ref-type="ref"}, [18](#dme13606-bib-0018){ref-type="ref"}, [19](#dme13606-bib-0019){ref-type="ref"} were also searched.

Study selection {#dme13606-sec-0009}
---------------

For the direction of anxiety to incident diabetes, eligible studies were prospective studies that assessed the incidence of diabetes in people aged 16 or over who were assessed for the presence of anxiety at baseline. To examine diabetes to incident anxiety, studies were required to be prospective studies that assessed the incidence of anxiety in people aged 16 or over who were assessed for the presence of diabetes at baseline. Only studies that examined Type 1 and/or Type 2 diabetes were included. Included studies were required to assess anxiety symptoms (as defined by elevated anxiety symptoms on a validated scale) or anxiety disorders (as assessed by diagnostic interview or clinical diagnosis). In this review, anxiety was defined as the anxiety disorders included in Diagnostic and Statistical Manual (DSM) version IV or V; version V excludes post‐traumatic stress disorder (PTSD) and obsessive--compulsive disorder (OCD) whereas version IV includes these disorders. For both research questions, exclusion criteria included a cross‐sectional study design, studies that did not assess incidence (i.e. did not control for baseline levels of the outcome) and those that explicitly assessed gestational diabetes. There were no restrictions set on the type of population included.

Two authors (KS and SD) independently screened all studies for these criteria (see Fig. [1](#dme13606-fig-0001){ref-type="fig"}), and disagreements were resolved by consensus or, where necessary, a third author (NS). Studies that were shortlisted after full‐text assessment were put forward for data extraction and quality assessment.

![PRISMA flow diagram: study selection](DME-35-677-g001){#dme13606-fig-0001}

Data extraction and quality assessment {#dme13606-sec-0010}
--------------------------------------

Data extraction and quality assessment were completed independently by two authors (KS and SD) with disagreements resolved by consensus. The following characteristics were extracted from eligible studies: author (date), study characteristics (name, country, number of participants), sample characteristics (% female, ethnicity and age), anxiety measurement (name of measure, information regarding type of anxiety assessed), diabetes measurement, outcome information (follow‐up length, % developed outcome), statistical analysis (type of statistical test and confounders controlled for) and measures of association (unadjusted and/or most‐adjusted estimate).

Quality assessment was performed using two tools: the Newcastle--Ottawa Scale (NOS) [20](#dme13606-bib-0020){ref-type="ref"} and the Risk Of Bias In Non‐randomized Studies of Interventions (ROBINS‐I) [21](#dme13606-bib-0021){ref-type="ref"}. We opted to use both tools because the NOS offers a good overview of study methodology and representativeness, whereas the ROBINS‐I offers a more comprehensive assessment of bias. The following characteristics were assessed using the NOS: representativeness of sample (community sample), selection of controls (same population as sample), measure of predictor and outcome (validated measurements), demonstration that outcome not present at start of study, length of follow‐up (≥ 5 years), adequacy of follow‐up participation rate (\> 60%), inclusion of at least three important confounders and if the study controlled for the most important confounder (metabolic abnormalities). Studies were assessed on a star system whereby they were given one star for each criterion met. Possible scores ranged from 0 to 9, with higher scores being indicative of better study quality. See Table [S1](#dme13606-sup-0003){ref-type="supplementary-material"} for NOS quality assessment.

Use of the ROBINS‐I requires pre‐identification of the most important confounders to assess bias. For the present review assessing the direction of anxiety to diabetes, the most important confounders were determined to be sociodemographic characteristics (e.g. age, sex, ethnicity, education, income) and cardiometabolic abnormalities (e.g. adiposity, blood pressure, inflammation, cholesterol, triglycerides). For the direction of diabetes to anxiety, the most important confounders were determined to be sociodemographic characteristics and other chronic conditions. Choice of confounders was based on these variables sharing a potentially explanatory association between the relevant predictor and outcome [10](#dme13606-bib-0010){ref-type="ref"}, [11](#dme13606-bib-0011){ref-type="ref"}, [18](#dme13606-bib-0018){ref-type="ref"}. The ROBINS‐I assessed studies on the following characteristics: bias due to confounding, bias in selection of participants into study, bias due to deviations from intended interventions, bias due to missing data, bias in measurement of outcomes and bias in selection of the reported result. Following the assessment of bias in each domain the authors independently judged the overall risk of bias as: critical, serious, moderate or low. See Table [S2](#dme13606-sup-0004){ref-type="supplementary-material"} for the ROBINS‐I quality assessment.

In addition to the quantitative quality assessments, both screening authors also undertook a qualitative quality assessment to independently determine the main strengths and limitations of each included study.

Meta‐analysis {#dme13606-sec-0011}
-------------

Eligible data were entered into a random‐effects meta‐analysis because this provides more conservative estimates allowing for more heterogeneity between studies. If studies provided stratified analyses for their predictor (e.g. analyses stratified by gender) these were first combined into a single estimate. We then plotted the least adjusted (unadjusted or adjusted for age only) association, followed by the most adjusted. For the least adjusted association, we either used odds ratios (ORs; unadjusted or adjusted for age only) or calculated the OR using raw event data. For each association, we performed a series of sensitivity analyses to assess the impact of methodological study differences (e.g. population studied, confounders controlled for, anxiety assessment) on the strength of the associations.

Alongside the meta‐analyses we determined statistical heterogeneity for each analysis by calculating the inconsistency (*I* ^2^) index (scores of 25%, 50% and 75% indicate low, moderate and high heterogeneity, respectively). Publication bias was assessed by visual inspection of funnel plots and Egger\'s test, with symmetric funnel plots and a non‐significant Egger\'s test being indicative of no publication bias. All analyses were performed with Comprehensive Meta‐Analysis 3.0 (Biostat, Englewood, NJ, USA).

Results {#dme13606-sec-0012}
=======

Study selection {#dme13606-sec-0013}
---------------

In total, 5418 studies were found after excluding duplicates (Fig. [1](#dme13606-fig-0001){ref-type="fig"}). After applying broad screening criteria, 5295 studies were excluded. The main reasons for excluding studies were that they did not assess the predictor or outcome of interest, the study was conducted in a non‐human population, language restrictions or that the study was cross‐sectional. A total of 124 studies were put forward for full‐text analysis, following which 108 were excluded. Reasons for exclusion were that the study did not assess incidence of diabetes or anxiety, the study was a poster presentation with no full‐text access for data extraction, the study was cross‐sectional and the study did not perform the analysis required for inclusion in this review. Inter‐rater reliability for study screening was good (kappa = 0.72).

Of the remaining 16 studies, 14 examined the direction of association from anxiety to incident diabetes and two examined the direction of association from diabetes to incident anxiety. Table [1](#dme13606-tbl-0001){ref-type="table-wrap"} summarizes the characteristics of the studies. Table [2](#dme13606-tbl-0002){ref-type="table-wrap"} summarizes the quality assessments performed for all studies along with a qualitative synthesis of the main study strengths and weaknesses as identified by the reviewers (for the full quality assessment tables see Tables [S1](#dme13606-sup-0003){ref-type="supplementary-material"} and [S2](#dme13606-sup-0004){ref-type="supplementary-material"}). Most studies (*n* = 11) were from North America [22](#dme13606-bib-0022){ref-type="ref"}, [23](#dme13606-bib-0023){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [26](#dme13606-bib-0026){ref-type="ref"}, [27](#dme13606-bib-0027){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [29](#dme13606-bib-0029){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, with an additional three studies from Europe [33](#dme13606-bib-0033){ref-type="ref"}, [34](#dme13606-bib-0034){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, one from Asia [36](#dme13606-bib-0036){ref-type="ref"} and one from the Middle‐East [37](#dme13606-bib-0037){ref-type="ref"}.

###### 

Characteristics of included studies

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year; country                                                              Study                                                                                                                Baseline sample                                              Anxiety measurement                                                                                                                         Diabetes incidence Measurement                                                                                                                                                       Incident diabetes cases                                                                                                                                                                                                                                            Statistical analysis                                                                Confounders adjusted                                                              Results                                                                                                                                                                                                                                                                                                                                                                                                                                       
  ---------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- --------------------------------
  Anxiety to incident diabetes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Abraham *et al*., 2015 [22](#dme13606-bib-0022){ref-type="ref"}; USA               The Multi‐Ethnic Study of Atherosclerosis (MESA)\                                                                    Age: 45--85 years (mean 61.6 years)\                         Spielberger Trait Anxiety Scale.\                                                                                                           Trait anxiety (current)                                                                                                                                                              Fasting glucose ≥ mmol/l (126 mg/dl), use of oral hypoglycaemic medication and/or insulin, or self‐reported physician diagnosis                                                                                                                                    695 (12.4%)\                                                                        Cox proportional hazards regression (reference group: Q1)                         Sex, age, race/ethnicity, years of education, annual income         Waist circumference, blood pressure, C‐reactive protein.            Depressive symptoms, antidepressants, diet, smoking, alcohol use, interleukin‐6                                                                                                                                                                                      Q2: HR 1.02 (0.83--1.26)\        Q2: HR 0.98 (0.78--1.23)\
                                                                                     *N* = 5566                                                                                                           Sex: 53.2% female\                                           (Quartiles Q1 \< 13; Q2 = 13--15; Q3 = 16--19; Q4 = 20--40)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Follow‐up: 11.4 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Q3: HR 0.99 (0.80--1.23)\        Q3: HR 0.99 (0.78--1.26)\
                                                                                                                                                                                                          Ethnicity:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Q4: HR 1.16 (0.93--1.45)         Q4: HR 1.16 (0.87--1.54)
                                                                                                                                                                                                          38% white, 28% African American, 23% Hispanic, 11% Chinese                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Atlantis *et al*, 2013 [33](#dme13606-bib-0033){ref-type="ref"}; The Netherlands   Netherlands\                                                                                                         Age: 18--65 years (mean 42)\                                 \(A\) 21‐item Beck Anxiety Inventory\                                                                                                       \(A\) Anxiety symptom severity (past month)\                                                                                                                                         Self‐report for lifetime diagnosis, anti‐diabetic medication use, or fasting plasma glucose ≥ 7.0 mmol/l                                                                                                                                                           25 incident diabetes cases (1.3%)\                                                  Logistic regression (predictor= every 10‐point increase BAI)                      --                                                                  --                                                                  --                                                                                                                                                                                                                                                                   OR 1.6 (1.2--2.1)                --
                                                                                     Study of Depression and Anxiety (NESDA)\                                                                             Sex: 66% female\                                             (B) Composite International Diagnostic Interview (CIDI)                                                                                     (B) Anxiety disorder: Social phobia, generalized anxiety disorder, panic disorder and/or agoraphobia (6‐month)                                                                                                                                                                                                                                                                                                                                          Follow‐up: 2 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                     *N* = 2460                                                                                                           Ethnicity: not specified                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Boyko *et al*, 2010 [23](#dme13606-bib-0023){ref-type="ref"}; USA                  Millennium Cohort Study\                                                                                             Age: 18--68 years (median 36 years)\                         PTSD: 17‐item PCL‐C (moderate or higher level one intrusion symptom, three avoidance symptoms, and two hyperarousal symptoms)\              PTSD symptoms (past month)\                                                                                                                                                          Self‐report                                                                                                                                                                                                                                                        376 incident diabetes cases (0.01%)\                                                Logistic regression                                                               Age, sex, ethnicity, educational attainment                         BMI                                                                 --                                                                                                                                                                                                                                                                   *PTSD*\                          *PTSD*\
                                                                                     *N* = 44 754                                                                                                         *No incident diabetes* Sex: 26.4% female\                    Panic: PHQ (endorsed eight items asking about whether had panic attacks and cognitions about panic attack)\                                 Panic disorder symptoms (2 weeks)\                                                                                                                                                                                                                                                                                                                                                                                                                      Follow‐up: 3 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 OR 2.56 (1.78--3.67)\            OR 2.24 (1.54--3.26)\
                                                                                                                                                                                                          Ethnicity: 71.8% Caucasian\                                  Other anxiety: PHQ (endorsed item, asking about feeling nervous, anxious, on edge, and at least three of six additional anxiety symptoms)   Other anxiety symptoms (2 weeks)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           *Panic disorder*\                *Panic disorder*:\
                                                                                                                                                                                                          11.6% African American\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             OR 3.19 (1.78--5.71)\            OR 2.88 (1.58--5.24)\
                                                                                                                                                                                                          5.8% Hispanic\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      *Other anxiety*\                 *Other anxiety*\
                                                                                                                                                                                                          8.6% Asian\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         OR 2.03 (1.16--3.54)             OR 1.77 (1.00--3.13)
                                                                                                                                                                                                          2.2% other\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                          *Incident diabetes* Sex: 27.7% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                          Ethnicity: 65.2% Caucasian\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                          18.9% African American\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                          6.3% Hispanic\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                          7.4% Asian\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                          2.2% other                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Chien & Lin, 2016 [36](#dme13606-bib-0036){ref-type="ref"}; Taiwan                 Taiwan National Health Insurance (NHI) program\                                                                      Age: 18 + years (mean not specified)\                        ICD‐9‐CM diagnostic codes (at least two service claims during 2005 for either outpatient or inpatient care)                                 Anxiety states, panic disorder, generalize anxiety disorder, phobic disorder, obsessive‐compulsive disorder, acute stress disorder, and post‐traumatic stress disorder (past year)   At least one prescription (oral hypoglycaemic agents or insulin) for treatment of diabetes                                                                                                                                                                         37 032 incident cases\                                                              Cox regression model                                                              Age, sex, insurance amount, region, and urbanicity                  --                                                                  --                                                                                                                                                                                                                                                                   --                               RR 1.34 (1.28--1.41)
                                                                                     *N* = 766 427                                                                                                        *Anxiety group*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Follow‐up: 5 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                          Sex: 11.88% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                          *Control group*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                          Sex: 5.77% female                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Demmer *et al*., 2015 [24](#dme13606-bib-0024){ref-type="ref"}; USA                First National Health and Nutrition Examination Survey (NHANES I) and its epidemiological follow‐up study (NHEFS)\   Age: 25--74 years (mean 49 ± 14 years)\                      General Wellbeing Scale: Anxiety subscale (GWB‐A): high (0--12), moderate (13--18), low (19--25)                                            Anxiety symptoms (past month)                                                                                                                                                        \(A\) Death certificate ICD‐9 code specifies diabetes\                                                                                                                                                                                                             298 incident cases (9.2%)\                                                          \(A\) Multivariable adjusted risk ratios from fitted logistic regression models   Age, race, education,                                               BMI                                                                 Smoking status, and physical activity                                                                                                                                                                                                                                *Moderate anxiety*\              *Moderate anxiety*\
                                                                                     *N* = 3233                                                                                                           Sex: 2% female\                                                                                                                                                                                                                                                                                                                                                                               (B) Self‐reported physician diagnosis requiring medication\                                                                                                                                                                                                        Follow‐up: 17 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Women: RR 1.33 (0.73--2.40)\     Women: RR 1.42 (0.78--2.61)\
                                                                                                                                                                                                          Ethnicity:\                                                                                                                                                                                                                                                                                                                                                                                   (C) Healthcare facility stay with diabetes discharge diagnosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Men: RR 0.89 (0.57--1.38)\       Men: RR 0.94 (0.61--1.44)\
                                                                                                                                                                                                          86% white\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          *High anxiety*\                  *High anxiety*\
                                                                                                                                                                                                          14% African American                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Women: RR 2.15 (1.24--3.74)\     Women: RR 1.72 (0.86--3.44)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Men: RR 0.68 (0.32--1.42)        Men: RR 0.70 (0.32--1.55)

  Deschênes *et al*., 2016 [25](#dme13606-bib-0025){ref-type="ref"}; Canada          Emotional Well‐being, Metabolic Factors and Health Status (EMHS) study\                                              Age: 40--69 years\                                           Generalized anxiety disorder questionnaire -- 7‐item (≥ 10 high anxiety)                                                                    Generalized anxiety symptoms (2 weeks)                                                                                                                                               Self‐report                                                                                                                                                                                                                                                        86 incident cases (3.5%)\                                                           Logistic regression                                                               Age, sex, ethnicity, education, marital status                      Central obesity, hypertension, triglycerides, HDL‐cholesterol       IPAQ score (physical activity), smoking status, antidepressant use                                                                                                                                                                                                   *High anxiety no prediabetes*\   *High anxiety no prediabetes*\
                                                                                     *N* = 2486                                                                                                           Sex: 57.4% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Follow‐up: 4.6 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               OR 0.92 (0.21--4.04)\            OR 1.13 (0.25--5.10)\
                                                                                                                                                                                                          Ethnicity: 93.3% white\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             *High anxiety prediabetes*\      *High anxiety prediabetes*\
                                                                                                                                                                                                          6.7% non‐white                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      OR 10.95 (5.24--22.90)           OR 8.95 (3.54--22.63)

  Edwards and Mezuk., 2012 [26](#dme13606-bib-0026){ref-type="ref"}; USA             Baltimore Epidemiologic Catchment Area\                                                                              Age: 30+ years\                                              Diagnostic Interview Schedule (DIS)                                                                                                         Anxiety disorders:generalized anxiety disorder, social phobia, panic disorder, and agora‐phobia                                                                                      Self‐report                                                                                                                                                                                                                                                        85 incident cases (4.4%)\                                                           Logistic regression                                                               Age, race/ethnicity, education, income, marital status              BMI                                                                 Tobacco use, physical activity, alcohol use, and sleeping habits\                                                                                                                                                                                                    OR 1.21 (0.72--2.03)             OR 1.00 (0.53--1.89)
                                                                                     Study\                                                                                                               Sex: 68.5% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Follow‐up: 11 years                                                                                                                                                                                                                                                                                           Major depressive disorder                                                                                                                                                                                                                                                                             
                                                                                     *N* = 1446                                                                                                           Ethnicity: 63% white\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                          33% black                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Farvid *et al*., 2014 [27](#dme13606-bib-0027){ref-type="ref"}; USA                Nurses\' Health Study (NHS)\                                                                                         *NHS*\                                                       \(A\) Crown‐Crisp index (CCI) (Continuous)\                                                                                                 Phobic anxiety (current)                                                                                                                                                             Questionnaire:\                                                                                                                                                                                                                                                    *NHS*\                                                                              Cox proportional hazards models                                                   Age, race, marital status, husband education (in NHS and NHS II).   BMI                                                                 Family history of diabetes, current aspirin use, menopausal status and hormone use (in NHS and NHS II), smoking status, alcohol intake, physical activity, energy intake, dietary score, coffee                                                                      (A)\                             (A)\
                                                                                     *N* = 69 336\                                                                                                        Age 30--55 years, Sex: 100% female\                          (B) CCI ≥ 6 vs. ≤ 2                                                                                                                                                                                                                                                                                                              (A) One or more classic symptom (excessive thirst, polyuria, weight loss, hunger) plus fasting plasma glucose ≥ 140 mg/dl or random plasma glucose ≥ 200 mg/dl\                                                                                                    6180 incident cases\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *NHS*\                           *NHS*\
                                                                                     Nurses\' Health Study II (NHS II)\                                                                                   *NHS II*\                                                                                                                                                                                                                                                                                                                                                                                     (B) ≥ 2 elevated plasma glucose concentrations on different occasions (fasting concentrations ≥ 140 mg/dl, random plasma glucose ≥ 200 mg/dl and/or concentrations glucose ≥ 200 mg/dl after 2‐h OGTT.\                                                            Follow‐up: 20 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               HR 1.06 (1.05--1.07)\            HR 1.03 (1.02--1.04)\
                                                                                     *N* = 80 120\                                                                                                        Age 24--43 years\                                                                                                                                                                                                                                                                                                                                                                             N.B. For cases diagnosed on/after 1998 fasting glucose ≥ 126 mg/dl.                                                                                                                                                                                                *NHS II*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          *NHS II*\                        *NHS II*\
                                                                                     Health Professional\'s Follow‐Up Study (HPFS)\                                                                       Sex: 100% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                4401 incident cases\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               HR 1.11 (1.09--1.12)\            HR 1.04 (1.03--1.05)\
                                                                                     *N* = 30 830                                                                                                         *HPFS*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Follow‐up: 18 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *HPFS*\                          *HPFS*\
                                                                                                                                                                                                          Age 40--75 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                *HPFS*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            HR 1.04 (1.02--1.06)\            HR 0.99 (0.97--1.01)\
                                                                                                                                                                                                          Sex: 0% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2295 incident cases\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               (B)\                             (B)\
                                                                                                                                                                                                          Ethnicity all studies: \~ 98% white                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Follow‐up: 20 years\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *NHS*\                           *NHS*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           N.B.: For HPFS incident cases reported as 2304, but according to table it is 2295                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  HR 1.06 (1.05--1.07)\            HR 1.13 (1.05--1.22)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              *NHS II*\                        *NHS II*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              HR 1.11 (1.09--1.12)\            HR 1.29 (1.18--1.42)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              *HPFS*\                          *HPFS*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              HR 1.04 (1.02--1.06)\            HR 0.90 (0.75--1.01)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              N.B. age adjusted                

  Khambaty *et al*., 2017 [28](#dme13606-bib-0028){ref-type="ref"}; USA              Improving Mood‐Promoting Access to Collaborative Treatment (IMPACT) trial\                                           Age: 60 + years (mean 69.0 ± 7.3 years)\                     PHQ‐2 (nerves or feeling anxious or on edge, worrying about a lot of different things).\                                                    Anxiety symptoms (past month)                                                                                                                                                        Medical records and insurance database: (ICD‐9 code 250), fasting glucose of ≥ 126 mg/dl, HbA~1c~ of ≥ 8.0%, prescription for insulin or oral hypoglycaemic medication, or death due to diabetes mellitus (ICD‐10 codes E10‐E14 as first‐listed cause of death).   558 incident cases (25.9%)\                                                         Cox proportional hazards models                                                   Age, sex, race                                                      BMI, hypertension, hypercholesterolaemia                            Smoking.                                                                                                                                                                                                                                                             --                               *Anxiety (either item)*\
                                                                                     *N* = 2156                                                                                                           Sex: 68.9% female\                                           Anxiety: endorsed both screening items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Follow‐up: 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 HR 1.36 (1.15--1.61)\
                                                                                                                                                                                                          Ethnicity: 53.3% African American                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    *Feeling anxious item*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               HR 1.26 (1.06--1.51)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *Worry item*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               HR 1.28 (1.07--1.52)

  Miller‐Archie *et al*., 2014 [30](#dme13606-bib-0030){ref-type="ref"}; USA         The World Trade Center Health Registry\                                                                              Age: 18+ years\                                              9/11‐specific PTSD Checklist (PCL), (PTSD ≥ 44)                                                                                             PTSD symptoms (past month)                                                                                                                                                           Self‐report                                                                                                                                                                                                                                                        2143 incident cases (5.8%)\                                                         Logistic regression                                                               Sex, age, race/ethnicity, education                                 Hypertension, high cholesterol, BMI                                 --                                                                                                                                                                                                                                                                   OR 1.73 (1.56--1.93)             OR 1.28 (1.14--1.44)
                                                                                     *N* = 36 899                                                                                                         *With incident diabetes*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Follow‐up: 9 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                          Sex: 34.6% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                          *Without incident diabetes*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                          Sex: 38.4% female                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Pérez‐Piñar *et al*., 2016 [35](#dme13606-bib-0035){ref-type="ref"}; UK            All patients, aged ≥30 years, registered in 140 primary care practices in London\                                    Age: 30+ years (mean 45.9 ± 13.9 years)\                     Anxiety Read codes                                                                                                                          Anxiety: Anxiety states, phobic disorders, other anxiety disorders, phobic anxiety disorders, generalized anxiety)                                                                   Diabetes read codes                                                                                                                                                                                                                                                31 942 incident cases (6.3%)\                                                       Cox regression models, hazard ratios                                              Age, gender, ethnicity, and social deprivation                      --                                                                  Antidepressants, antipsychotics                                                                                                                                                                                                                                      --                               HR 1.14 (1.08, 1.20)
                                                                                     *N* = 524 952                                                                                                        Sex: 47.1% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Follow‐up: 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                          Ethnicity: 41.9% white\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                          27.6% South Asian\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                          17.0% black\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                          6.2% other\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                          7.3% unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Scherrer *et al*., 2011 [31](#dme13606-bib-0031){ref-type="ref"}; USA              National VA Administrative Data\                                                                                     Age: 25‐80 years (mean 55.6 ± 13.1 years)\                   ICD‐9 codes                                                                                                                                 PTSD\                                                                                                                                                                                Diabetes assessed by ICD‐9‐CM code                                                                                                                                                                                                                                 28 535 incident cases (15.4%)\                                                      \(A\) Cox proportional hazard models\                                             Age                                                                 BMI (PTSD)                                                          PTSD (GAD)                                                                                                                                                                                                                                                           *PTSD*\                          *PTSD*\
                                                                                     *N* = 184 925                                                                                                        Sex: 9.6% female\                                                                                                                                                                                        GAD\                                                                                                                                                                                                                                                                                                                                                                                                                                                    Follow‐up: 6 years                                                                  (B) Number of events                                                                                                                                                                                                                                                                                                                                                                                                                                                                           HR 1.25 (1.21--1.29)\            HR 1.25 (1.21--1.29)\
                                                                                                                                                                                                          Ethnicity: 75.5% white\                                                                                                                                                                                  Panic\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *GAD*\                           *GAD*\
                                                                                                                                                                                                          20% non‐white\                                                                                                                                                                                           Other anxiety                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              HR 1.07 (1.01--1.13)             HR 1.09 (1.06--1.12)
                                                                                                                                                                                                          4.5% unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Shirom *et al*., 2010 [37](#dme13606-bib-0037){ref-type="ref"}; Israel             Clarlit health services database\                                                                                    Age: 18--73 years (mean 41.70 years)\                        Cornell Medical Index:\                                                                                                                     Anxiety symptoms (how they feel most of the time)                                                                                                                                    ICD‐9 codes cross‐validated against medication use files and serum analysis of HbA~1c~ for the diagnosis of diabetes                                                                                                                                               109 incident cases (12.5%)\                                                         Cox proportional hazards regression                                               Age, sex,\                                                          BMI, cholesterol, triglycerides, arterial blood pressure, glucose   Smoking, exercise, alcohol consumption, vigour, depressive symptoms                                                                                                                                                                                                  --                               HR 1.00 0.78--1.26
                                                                                     N = 870                                                                                                              Sex: 33% female                                              Unclear how this was scored but most likely continuous (0--5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Follow‐up: 20 years                                                                                                                                                   educational level                                                                                                                                                                                                                                                                                                                                                                                                                             

  Vaccarino *et al*., 2014 [32](#dme13606-bib-0032){ref-type="ref"}; USA             Vietnam Era Twin Registry\                                                                                           Age: 18+ years\                                              Diagnostic Interview Schedule (DIS)\                                                                                                        PTSD (lifetime)                                                                                                                                                                      Self‐reported (doctor diagnosis and medication)                                                                                                                                                                                                                    658 incident cases (15.2%)\                                                         Multivariate logistic regression                                                  Age, race, ethnicity, marital status, education                     BMI, hypertension, hypercholesterolaemia                            Branch of service, enlistment year, service in Southeast Asia, and military rank at enlistment, cigarette smoking, alcohol use, physical activity, history of cardiovascular disease, depression, generalized anxiety disorder, and alcohol or drug abuse disorder   *Subthreshold PTSD*\             *Subthreshold PTSD*\
                                                                                     *N* = 4340                                                                                                           Sex: 0% female\                                              Subthreshold PTSD was defined by meeting some, but not all, criteria for PTSD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Follow‐up: median 19.4 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       OR 1.2 (0.8--1.7)\               OR 1.2 (0.9--1.5)\
                                                                                                                                                                                                          Ethnicity: 90.1% white                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              *PTSD*\                          *PTSD*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              OR 1.0 (0.6--1.7)\               OR 1.2 (0.9--1.7)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              N.B. adjusted for age            

  Diabetes to incident anxiety                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Engum *et al*., 2007 [34](#dme13606-bib-0034){ref-type="ref"}; Norway              HUNT‐1 (1984--1986) and HUNT‐2 (1995--1997)\                                                                         Age: 30--89 years\                                           Self‐report (type of diabetes determined by using glutamic acid decarbox‐ylase, C‐peptide tests, and start of insulin treatment)            Baseline: ADI\                                                                                                                                                                       ADI: General self‐report anxiety symptoms\                                                                                                                                                                                                                         *N* = 2841 incident cases\                                                          Logistic regression                                                               Age, gender, educational level, and marital status                  ‐                                                                   ‐                                                                                                                                                                                                                                                                    *Type 1 diabetes*\               *Type 1 diabetes*\
                                                                                     *N* = 37 291                                                                                                         *Anxious/ depressed group*\                                                                                                                                                                              Follow‐up HADS‐A: \> 8 anxiety                                                                                                                                                       HADS‐A: Past‐week self‐reported anxiety symptoms                                                                                                                                                                                                                   Follow‐up: 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                OR 0.47 (0.15--1.51)\            OR 0.50 (0.16‐1.61)\
                                                                                                                                                                                                          Sex: 59.1% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  *Type 2 diabetes*\               *Type 1 diabetes*\
                                                                                                                                                                                                          *Non‐anxious/ depressed group*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     OR 0.76 (0.42--1.37)             OR 0.76 (0.42--1.37)
                                                                                                                                                                                                          51.0% female                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Marrie *et al*., 2016 [29](#dme13606-bib-0029){ref-type="ref"}; Canada             Administrative data from Alberta\                                                                                    Age: mean \~ 42.8 years\                                     ICD‐9 or 10 codes                                                                                                                           ICD codes for anxiety disorders                                                                                                                                                      Anxiety disorders\                                                                                                                                                                                                                                                 No information incident anxiety\                                                    Cox proportional hazards models                                                   Age, sex, index year (for MS), SES                                  --                                                                  Hypertension, ischaemic heart disease, hyperlipidaemia, lung disease, fibromyalgia, epilepsy, inflammatory bowel disease (physical comorbidities time‐varying)                                                                                                       ‐                                *Combined populations*\
                                                                                     *N* = 50 818\                                                                                                        *MS cases*\                                                                                                                                                                                                                                                                                                                                                                                   Length: not specified.                                                                                                                                                                                                                                             Follow‐up: \~ 10 years                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              HR 1.11 (0.99--1.25)\
                                                                                     (9624 persons with MS, and 41 194 matches)                                                                           Sex: 68.9% female\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   *Matched controls*\
                                                                                                                                                                                                          *Controls* Sex: 67.0% female                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         HR 1.09 (0.95--1.24)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               *MS population only*\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               HR 1.22 (0.94--1.58)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ADI, Anxiety and Depression Inventory; HADS‐A: Hospital Anxiety and Depression Scale; GAD, *generalized anxiety disorder*; HR, hazard ratio; ICD, International Statistical Classification of Diseases and Related Health Problems; MS, multiple sclerosis; OR, odds ratio; PCL‐C, PTSD checklist Civilian version; PHQ, Patient Health Questionnaire; PTSD, post‐traumatic stress disorder; RR, risk ratio; VA: Veterans Affairs

John Wiley & Sons, Ltd

###### 

Quality assessment of included studies

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                                                            NOS score (maximum 9)   ROBINS‐I overall risk of bias   Most important study limitations and strengths (qualitative assessment)
  ----------------------------------------------------------------------- ----------------------- ------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Abraham *et al*., 2015 [22](#dme13606-bib-0022){ref-type="ref"}         9                       Low/moderate                    *Limitations*: Used self‐report trait anxiety scale split into data‐driven quartiles rather than validated cut‐offs being used.\
                                                                                                                                  *Strengths*: Large, representative multi‐ethnic cohort. Comprehensive diabetes assessment (excluded people possible undiagnosed diabetes). Comprehensive set of confounders controlled for.

  Atlantis *et al*., 2012 [33](#dme13606-bib-0033){ref-type="ref"}        5                       Serious                         *Limitations*: Lack of confounder control. Short length of follow‐up and few people developed diabetes. Main analysis based on 10‐point increase in anxiety scores (not a validated cut‐off).\
                                                                                                                                  *Strengths*: Large population specifically sampled for anxiety and depression. Event data for anxiety disorders based on diagnostic interviews available.

  Boyko *et al*., 2010 [23](#dme13606-bib-0023){ref-type="ref"}           5                       Moderate                        *Limitations*: Military population only so limited generalizability. Fully adjusted analysis was a backwards multiple regression so fully adjusted estimates of interest could not be included. Self‐report scales for anxiety (although applied diagnostic criteria) and self‐report diabetes.\
                                                                                                                                  *Strengths*: Large sample size.

  Chien and Lin, 2016 [36](#dme13606-bib-0036){ref-type="ref"}            8                       Moderate                        *Limitations*: Administrative database (may underestimate anxiety and diabetes). No control cardiometabolic confounders. No crude estimate. Diagnostic codes included disorders no longer considered anxiety disorders (e.g. PTSD).\
                                                                                                                                  *Strengths*: Large non‐Western population.

  Demmer *et al*., 2015 [24](#dme13606-bib-0024){ref-type="ref"}          8                       Moderate                        *Limitations*: Used self‐report anxiety scale. Lack of control for cardiometabolic abnormalities (other than BMI).\
                                                                                                                                  *Strengths*: Large representative population with long follow‐up. Comprehensive assessment of incident diabetes.

  Deschênes *et al*., 2016 [25](#dme13606-bib-0025){ref-type="ref"}       6                       Moderate                        *Limitations*: Oversampled people with depression and metabolic abnormalities from pre‐existing dataset not representative population. Low diabetes incidence. Ethnically homogenous sample.\
                                                                                                                                  *Strengths*: Large sample. Stratification by prediabetes status. Comprehensive set of confounders controlled for.

  Engum *et al*., 2007 [34](#dme13606-bib-0034){ref-type="ref"}           5                       /                               *Limitations*: Different assessment baseline and follow‐up anxiety. No control cardiometabolic confounders. Self‐report anxiety and diabetes. No description missing data. Ascertainment bias possibility (only one follow‐up in 10 years).\
                                                                                                                                  *Strengths*: Large representative sample.

  Edwards and Mezuk, 2012 [26](#dme13606-bib-0026){ref-type="ref"}        6                       Moderate/serious                *Limitations*: Lack of transparency in describing follow‐up data. Self‐report diabetes. No description time‐frame for anxiety. Relatively small number of participants with anxiety. Lack of control for cardiometabolic abnormalities (other than BMI).\
                                                                                                                                  *Strengths*: Large representative sample, some ethnic diversity. Used diagnostic interviews for anxiety.

  Farvid *et al*., 2014 [27](#dme13606-bib-0027){ref-type="ref"}          8                       Moderate                        *Limitations*: Healthcare professional populations only so limited generalizability. Self‐report anxiety scale assessing personality phobic anxiety rather than phobic anxiety disorder. Ethnically homogenous sample.\
                                                                                                                                  *Strengths*: Results from three studies provided. Large samples and long follow‐ups. Comprehensive assessment of diabetes.

  Khambaty *et al*., 2017 [28](#dme13606-bib-0028){ref-type="ref"}        8                       Moderate                        *Limitations*: Short anxiety screen rather than full anxiety scale or diagnostic interview. Non‐representative clinical population.\
                                                                                                                                  *Strengths*: Large population. Comprehensive assessment of diabetes. Transparency in reporting. Ethnically diverse sample.

  Marrie *et al*., 2016 [29](#dme13606-bib-0029){ref-type="ref"}          7                       Moderate/serious                *Limitations*: Not a representative study so limited generalizability (people with MS and matched controls). Administrative database (may underestimate anxiety and diabetes). No control cardiometabolic confounders.\
                                                                                                                                  *Strengths*: Large sample size.

  Miller‐Archie *et al*., 2014 [30](#dme13606-bib-0030){ref-type="ref"}   8                       Moderate                        *Limitations*: Not a representative sample (only people exposed to 9/11 disaster). PTSD only assessed (no longer anxiety disorder in DSM‐V). PTSD and diabetes assessed with self‐report. Not all confounders measured at baseline.\
                                                                                                                                  *Strengths*: Large sample.

  Pérez‐Piñar *et al*., 2016 [35](#dme13606-bib-0035){ref-type="ref"}     8                       Moderate/serious                *Limitations*: Primary care database (may underestimate anxiety and diabetes). No description time‐frame for anxiety. Lack of control for cardiometabolic abnormalities. Unadjusted estimates not available.\
                                                                                                                                  *Strengths*: Large ethnically diverse sample.

  Scherrer *et al*., 2011 [31](#dme13606-bib-0031){ref-type="ref"}        5                       Serious                         *Limitations*: Veteran population only so limited generalizability. Administrative database (may underestimate anxiety and diabetes). Limited adjustment for confounders.\
                                                                                                                                  *Strengths*: Large sample size

  Shirom *et al*., 2010 [37](#dme13606-bib-0037){ref-type="ref"}          8                       Moderate                        *Limitations*: Self‐report anxiety symptoms. Women under‐represented in sample and people with high SES overrepresented (sample not generalizable). PTSD only assessed (no longer anxiety disorder in DSM‐V).\
                                                                                                                                  *Strengths*: Good sized sample. Comprehensive set of confounders controlled for.

  Vaccarino *et al*., 2014 [32](#dme13606-bib-0032){ref-type="ref"}       7                       Low/moderate                    *Limitations*: Veteran population only so limited generalizability. Self‐report diabetes. Ethnically homogenous sample.\
                                                                                                                                  *Strengths*: Large sample. Used diagnostic interviews for anxiety. Comprehensive set of confounders controlled for.
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NOS, Newcastle--Ottawa Scale. For this scale studies were ranked out of nine stars for selection bias, information bias, comparability and quality.

ROBINS‐I (Risk of Bias in Non‐randomised studies of Interventions). For this scale studies were ranked for bias across six domains (confounding, selection of participants, classification of intervention, missing data, measurement of outcomes, reporting of results).

Qualitative assessment: the two study reviewers independently assessed the main strengths and limitations of the included studies.

John Wiley & Sons, Ltd

Because of the small number of studies examining diabetes to anxiety (*n* = 2) we put forward only those studies examining anxiety to diabetes for the quantitative synthesis (*n* = 14).

Study review {#dme13606-sec-0014}
------------

### Anxiety to incident diabetes {#dme13606-sec-0015}

In the 14 studies that examined the association between anxiety and incident diabetes, 115 418 people from a total of 1 760 800 (6.6%) developed incident diabetes (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Seven of the ten studies that provided an unadjusted or minimally adjusted estimate reported a significant association between baseline anxiety and incident diabetes [23](#dme13606-bib-0023){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [27](#dme13606-bib-0027){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}. Of the 13 studies that examined the most adjusted association between baseline anxiety and incident diabetes, eight found a significant association [23](#dme13606-bib-0023){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [27](#dme13606-bib-0027){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [36](#dme13606-bib-0036){ref-type="ref"}. Overall study quality was variable with 10 studies having low or moderate evidence of bias (see Table [2](#dme13606-tbl-0002){ref-type="table-wrap"}) and four having some serious bias issues [26](#dme13606-bib-0026){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}. In studies identified as having serious bias, bias was due to issues with adjustment for confounders, lack of transparency in reporting and participant sampling (Table [2](#dme13606-tbl-0002){ref-type="table-wrap"}).

Of the seven studies that found a significant least adjusted association between baseline anxiety and incident diabetes, two examined general anxiety symptoms [24](#dme13606-bib-0024){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}. Atlantis *et al*. [33](#dme13606-bib-0033){ref-type="ref"} found that for every 10‐point increase in the Beck Anxiety Index score there was a 1.6‐fold increase in the odds of developing incident diabetes over 2 years. However, they did not provide an adjusted estimate. Demmer *et al*. [24](#dme13606-bib-0024){ref-type="ref"} found that in women only, high anxiety symptoms as measured with the General Well‐Being Scale were associated with a 2.15 times increased likelihood of developing diabetes over 17 years. However, this association was attenuated after adjustment for sociodemographics, BMI and lifestyle characteristics, and no association between anxiety and diabetes was found in men [24](#dme13606-bib-0024){ref-type="ref"}. A further two studies found an association between generalized anxiety disorder (GAD) or GAD symptomatology with incident diabetes [25](#dme13606-bib-0025){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}. Deschênes *et al*. [25](#dme13606-bib-0025){ref-type="ref"} stratified their groups based on the presence of prediabetes and high anxiety symptoms measured with the GAD‐7 scale at baseline. They found that people with high anxiety and prediabetes had a 10.95 times increased odds of developing diabetes over 5 years compared with people with no prediabetes and no anxiety. This association remained significant after adjustment for a range of sociodemographic, cardiometabolic, lifestyle and medication confounders [25](#dme13606-bib-0025){ref-type="ref"}. However, this study also found that high anxiety symptoms in the absence of prediabetes were not associated with increased odds of developing diabetes (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Scherrer *et al*. [31](#dme13606-bib-0031){ref-type="ref"}, using data from a Veteran\'s database, found that doctor‐diagnosed GAD at baseline was associated with a 1.07 times increased hazard of developing incident diabetes over 6 years. This association remained significant after adjustment, however the authors only adjusted for BMI and age [31](#dme13606-bib-0031){ref-type="ref"}.

Of the four studies that examined the association between PTSD and incident anxiety [23](#dme13606-bib-0023){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, three found a significant association. Scherrer *et al*. [31](#dme13606-bib-0031){ref-type="ref"} found that veterans with doctor‐diagnosed PTSD at baseline had a 1.25 times increased hazard of developing incident diabetes, an association that remained significant after adjustment for BMI and age. Boyko *et al*. [23](#dme13606-bib-0023){ref-type="ref"} examined PTSD in a military population using a validated scale and found those endorsing PTSD symptoms had a 2.56 times increased odds of developing incident diabetes over 3 years, an association that remained significant after adjustment for sociodemographics and BMI. They also found that panic and other anxiety also predicted incident diabetes. Miller‐Archie *et al*. [30](#dme13606-bib-0030){ref-type="ref"} examined symptoms of PTSD in people exposed to a traumatic event and found that high baseline PTSD symptoms were associated with a 1.73 times increased odds of developing incident diabetes, an association that remained significant after controlling for sociodemographics and cardiometabolic abnormalities.

One article included data from three studies conducted in healthcare professionals and found that phobic anxiety symptoms at baseline were associated with an increased hazard of developing incident diabetes over 18--20 years in all three studies [27](#dme13606-bib-0027){ref-type="ref"}. However, the association in the study that only included men (Healthcare Professionals Study) was no longer significant after adjustment for confounders, whereas the two studies in women (Nurses Health Studies I and II) remained significant [27](#dme13606-bib-0027){ref-type="ref"}.

Of the four studies that did not provide unadjusted or minimally adjusted estimates, three found a significant association between baseline anxiety and incident diabetes[28](#dme13606-bib-0028){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [36](#dme13606-bib-0036){ref-type="ref"}. Chien and Lin [36](#dme13606-bib-0036){ref-type="ref"} used data from a Taiwanese insurance database to determine that diagnosed anxiety disorders were associated with a 1.34 times increased risk of developing incident diabetes over 5 years after adjusting for sociodemographics. Khambaty *et al*. [28](#dme13606-bib-0028){ref-type="ref"} measured anxiety with a short screening scale in older adults and found that after adjusting for sociodemographics, cardiometabolic characteristics and smoking, those with anxiety had a 1.36 times increased hazard of incident diabetes over 10 years. Pérez‐Piñar *et al*. [35](#dme13606-bib-0035){ref-type="ref"} used read codes in a primary care database to determine that diagnosed anxiety disorders were associated with a 1.14 times increased hazard of developing diabetes over 10 years after adjusting for sociodemographics and medication.

In total, three studies indicated there was no unadjusted or minimally adjusted association between either trait anxiety with incident diabetes [22](#dme13606-bib-0022){ref-type="ref"}, anxiety disorders with incident diabetes [26](#dme13606-bib-0026){ref-type="ref"} or PTSD symptoms with incident diabetes [32](#dme13606-bib-0032){ref-type="ref"}.

There was study heterogeneity in terms of follow‐up, measurement, population and analysis (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Study follow‐up ranged between 2 years [33](#dme13606-bib-0033){ref-type="ref"} and 20 years [27](#dme13606-bib-0027){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}. Studies with a shorter range of follow‐up (2--5 years) reported overall diabetes incidence rates of 0.01% to 3.5% [23](#dme13606-bib-0023){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"} compared with overall diabetes incidence rates of 4.4% to 25.9% in studies with a follow‐up of 10 years or more [22](#dme13606-bib-0022){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [26](#dme13606-bib-0026){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}. Types of anxiety measurements included the assessment of non‐specific anxiety symptoms, a composite of different anxiety disorders, PTSD, phobic anxiety symptoms, panic, GAD and/or other anxiety (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Anxiety was determined using a variety of validated symptom scales [22](#dme13606-bib-0022){ref-type="ref"}, [23](#dme13606-bib-0023){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [27](#dme13606-bib-0027){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}, diagnostic interviews [26](#dme13606-bib-0026){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"} and examination of medical records [31](#dme13606-bib-0031){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [36](#dme13606-bib-0036){ref-type="ref"}. Most studies examined general anxiety or defined anxiety or anxiety disorders using DSM‐V criteria [22](#dme13606-bib-0022){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}. However, three studies included anxiety disorders as defined by DSM‐IV [23](#dme13606-bib-0023){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [36](#dme13606-bib-0036){ref-type="ref"} and two studies only provided estimates for PTSD [30](#dme13606-bib-0030){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}.

All studies excluded people with diagnosed diabetes at baseline. Four studies also excluded people with high levels of blood glucose t baseline and assessed incident diabetes using blood glucose levels [22](#dme13606-bib-0022){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}. One study also explicitly accounted for prediabetes in their analysis [25](#dme13606-bib-0025){ref-type="ref"}. The remaining nine studies relied on self‐report or medical records, and therefore undiagnosed diabetes could be an issue with these studies (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Notably, most incident cases included in this direction of causality would have assessed incident Type 2 diabetes as studies were conducted in adult populations (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}).

There were also differences in the populations studied (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Three studies were conducted in veteran or military populations [23](#dme13606-bib-0023){ref-type="ref"}, [31](#dme13606-bib-0031){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, one study examined healthcare professionals [27](#dme13606-bib-0027){ref-type="ref"}, one study was conducted in people exposed to the 9/11 attacks in New York [30](#dme13606-bib-0030){ref-type="ref"}, two studies sampled people from a health insurance database [36](#dme13606-bib-0036){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}, two studies sampled people from primary care [28](#dme13606-bib-0028){ref-type="ref"}, [35](#dme13606-bib-0035){ref-type="ref"}, one study sampled a mixture of clinical and community populations [33](#dme13606-bib-0033){ref-type="ref"} and the remaining four studies were sampled from the community [22](#dme13606-bib-0022){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [25](#dme13606-bib-0025){ref-type="ref"}, [26](#dme13606-bib-0026){ref-type="ref"}. Furthermore, two studies oversampled people on the basis of anxiety and/or depression at baseline [25](#dme13606-bib-0025){ref-type="ref"}, [33](#dme13606-bib-0033){ref-type="ref"}.

Finally, there were differences in the analyses employed by researchers, with six studies calculating ORs, two studies calculating risk ratios (RRs) and six studies calculating hazards ratios (HRs) (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Furthermore, one study did not control for any confounders [33](#dme13606-bib-0033){ref-type="ref"}, one study only controlled for age and BMI [31](#dme13606-bib-0031){ref-type="ref"} and one study only controlled for sociodemographic confounders [36](#dme13606-bib-0036){ref-type="ref"}, whereas most studies controlled for a range of sociodemographic, cardiometabolic and other confounders \[[22](#dme13606-bib-0022){ref-type="ref"}, [24](#dme13606-bib-0024){ref-type="ref"}, [28](#dme13606-bib-0028){ref-type="ref"}, [30](#dme13606-bib-0030){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, [37](#dme13606-bib-0037){ref-type="ref"}\].

### Diabetes to incident anxiety {#dme13606-sec-0016}

Only two studies examined the association between diabetes and incident anxiety (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). Both studies had moderate to serious quality issues (Table [2](#dme13606-tbl-0002){ref-type="table-wrap"}). The first study by Engum *et al*. [34](#dme13606-bib-0034){ref-type="ref"} found no association between either Type 1 or Type 2 diabetes and incident anxiety symptoms over 10 years in a Norwegian population sample. Although the study included a large and representative sample, they used a different measure for anxiety at baseline and follow‐up, thereby limiting inferences about incidence (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}). The second study by Marrie *et al*. [29](#dme13606-bib-0029){ref-type="ref"} provided only fully adjusted estimates and found no association between diabetes and incident anxiety in an administrative database over 10 years of follow‐up. However, generalizability was limited by the fact that participants were sampled based on a diagnosis of multiple sclerosis or being a matched‐control for multiple sclerosis participants. Both studies found no association from diabetes to incident anxiety, however due to study quality and generalizability, inferences are limited.

### Implications of study review for meta‐analysis {#dme13606-sec-0017}

Because of the small number of studies for the direction of association from diabetes to incident anxiety, we could not move forward with a meta‐analysis for this direction. However, we had sufficient data to examine the direction of association from anxiety to incident diabetes. Owing to differences in analysis (Table [1](#dme13606-tbl-0001){ref-type="table-wrap"}) we opted to combine all studies for a least adjusted estimate using ORs or raw event data (either calculated from data provided in the paper or by contacting study authors) that were then converted to ORs (Table [S3](#dme13606-sup-0005){ref-type="supplementary-material"}). Furthermore, as one paper had analysed results from three studies separately [27](#dme13606-bib-0027){ref-type="ref"}, we opted to enter each study independently into the meta‐analysis. Owing to study heterogeneity, we then ran a series of sensitivity analyses on our results to determine whether those sources of heterogeneity we identified in our review would have any impact on the combined estimate. We opted to run a series of analyses stratified by definition of anxiety given that the current definition of anxiety disorders no longer includes disorders such as PTSD and OCD (DSM‐V), which were previously classified as anxiety disorders (DSM‐IV). We also examined most‐adjusted data, but these analyses were stratified by the estimate provided by the authors (i.e. OR or HR).

### Meta‐analysis {#dme13606-sec-0018}

Results from 15 studies across 13 publications were entered into a random‐effects meta‐analysis (Fig. [2](#dme13606-fig-0002){ref-type="fig"}). Unadjusted or age‐adjusted ORs and raw event data were combined (Table [S3](#dme13606-sup-0005){ref-type="supplementary-material"}). We were unable to access raw data for one study [37](#dme13606-bib-0037){ref-type="ref"}, however all other studies were included.

![Forest plot of least‐adjusted association between baseline anxiety and incident diabetes](DME-35-677-g002){#dme13606-fig-0002}

The pooled OR from the 15 studies was 1.47 (1.23--1.75). However, study heterogeneity was high (*I* ^2^ = 98.13) and the funnel plot (Fig. [S1](#dme13606-sup-0001){ref-type="supplementary-material"}) and Egger\'s test (*P* = 0.05) indicated the presence of publication bias. In analyses stratified by anxiety assessment type, diabetes assessment type, and most other general sensitivity analyses, the estimate mostly remained stable (Table [3](#dme13606-tbl-0003){ref-type="table-wrap"}). However, there was no significant association between anxiety and incident diabetes in sensitivity analyses that combined only studies that assessed baseline diagnosed anxiety disorders (as defined by DSM‐V criteria), studies that had some serious risk of bias, and studies that provided stratified estimates for men.

###### 

Sensitivity analysis and funnel plot for least‐adjusted analysis

                                                                                               Odds ratio          *I* ^2^
  -------------------------------------------------------------------------------------------- ------------------- ---------
  All studies                                                                                  1.47 (1.23--1.74)   98.13
  Minus largest study (Pérez‐Piñar *et al*. [35](#dme13606-bib-0035){ref-type="ref"})          1.49 (1.22--1.82)   98.20
  Minus most significant study (Deschênes *et al*. [25](#dme13606-bib-0025){ref-type="ref"})   1.38 (1.61--1.65)   98.1
  Low‐moderate risk of bias studies                                                            1.58 (1.53--1.64)   94.8
  Some serious risk of bias studies                                                            1.25 (0.93--1.68)   86.7
  Follow‐up 5 years or less                                                                    1.96 (1.87--2.06)   82.5
  Follow‐up 10 years or more                                                                   1.28 (1.24--1.33)   78.7
  Only including anxiety/anxiety disorder as defined in DSM‐V                                  1.36 (1.17--1.60)   94.7
  Anxiety disorders (DSM‐V)                                                                    1.24 (0.88--1.74)   97.6
  Anxiety symptoms (DSM‐V)                                                                     1.43 (1.22--1.67)   86.7
  PTSD only                                                                                    1.51 (1.07--2.13)   95.9
  Anxiety symptoms (with PTSD)                                                                 1.46 (1.28--1.71)   89.5
  Studies where people with possible undiagnosed diabetes at baseline excluded.                1.42 (1.15--1.76)   46.5
  Community population                                                                         1.86 (1.14--3.04)   88.0
  Men                                                                                          0.93 (0.79--1.09)   0
  Women                                                                                        1.35 (1.17--1.55)   76.1

DSM‐V anxiety disorders include: generalized anxiety disorder (GAD), panic, phobia. However, they no longer include post‐traumatic stress disorder (PTSD) and obsessive--compulsive disorder (OCD) which were classified as anxiety disorders until 2013. For those studies only including DSM‐V anxiety disorders or anxiety we excluded PTSD from the combined estimate for Boyko *et al*. [23](#dme13606-bib-0023){ref-type="ref"} and excluded PTSD from the combined estimate for Scherrer *et al*. [31](#dme13606-bib-0031){ref-type="ref"}. Anxiety disorders (DSM‐V) comprises only those studies where a diagnosis of anxiety disorders as defined by DSM‐V was included (thus Chien and Lin [36](#dme13606-bib-0036){ref-type="ref"} were excluded as they combined PTSD and OCD in their anxiety disorder estimate).
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When we examined the most adjusted associations stratified by type of analysis, all estimates indicated a significant association between baseline anxiety with incident diabetes (Table [4](#dme13606-tbl-0004){ref-type="table-wrap"}). The eight studies that calculated an adjusted HR estimate had a combined estimate of HR 1.14 (1.08--1.21) (for forest plot see Fig. [S2](#dme13606-sup-0002){ref-type="supplementary-material"}). Study heterogeneity was high for these studies (*I* ^2^ = 71.94), however there was little evidence of publication bias (Egger\'s test, *P* = 0.38; see Fig. S1 for funnel plot). The five studies that calculated an adjusted OR had a combined estimate of OR 1.64 (1.13--2.39) (for forest plot see Fig. [S2](#dme13606-sup-0002){ref-type="supplementary-material"}). Study heterogeneity was high (*I* ^2^ = 84.13), however Egger\'s test was non‐significant (*P* = 0.20; see Fig. [S1](#dme13606-sup-0001){ref-type="supplementary-material"} for funnel plot). Finally, the two studies that calculated an adjusted RR had a combined estimate of RR 1.34 (1.27 1.41) (for forest plot see Fig. [S2](#dme13606-sup-0002){ref-type="supplementary-material"}). Study heterogeneity was low for these studies (*I* ^2^ = 0).

###### 

Sensitivity analyses and funnel plots for most‐adjusted meta‐analysis anxiety to diabetes stratified by analysis type

                                                                                     Hazard ratio                                                                          Odds ratio                                                                            Risk ratio
  ---------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- -------------------
  All studies                                                                        1.14 (1.08--1.21)                                                                     1.64 (1.13--2.39)                                                                     1.34 (1.27--1.41)
  Minus largest study                                                                1.12 (1.03--1.23)                                                                     1.48 (0.99--2.20)                                                                     --
  Minus most significant study                                                       1.13 (1.06--1.20)                                                                     1.42 (1.03--1.95)                                                                     --
  Low--moderate risk of bias studies                                                 1.13 (0.99--1.28)                                                                     1.81 (1.19--2.75)                                                                     --
  Some serious risk of bias studies                                                  1.15 (1.13--1.18)                                                                     Insufficient data (only Edwards and Mezuk [26](#dme13606-bib-0026){ref-type="ref"})   --
  Follow up 5 years or less                                                          No studies                                                                            3.09 (1.41--6.76)                                                                     --
  Follow up 10 years or more                                                         1.14 (1.04--1.24)                                                                     1.15 (0.85--1.56)                                                                     --
  Only including anxiety/anxiety disorder as in DSM‐V                                1.14 (1.09--1.20)                                                                     2.06 (1.46--2.91)                                                                     --
  Anxiety disorder (DSM‐V)                                                           1.15 (1.13--1.18)                                                                     Insufficient data (only Edwards and Mezuk [26](#dme13606-bib-0026){ref-type="ref"})   --
  PTSD only                                                                          Insufficient data (only Scherrer *et al*. [31](#dme13606-bib-0031){ref-type="ref"})   1.47 (1.06--2.03)                                                                     --
  Anxiety disorder (DSM‐IV)                                                          1.15 (1.13--1.18)                                                                     Insufficient data (only Edwards and Mezuk [26](#dme13606-bib-0026){ref-type="ref"})   --
  Anxiety symptoms                                                                   1.16 (1.13--1.18)                                                                     1.81 (1.19--2.75)                                                                     --
  Studies where people with possible undiagnosed diabetes at baseline excluded       1.16 (1.13--1.18)                                                                     No studies                                                                            --
  Studies where people with possible undiagnosed diabetes at baseline not excluded   1.13 (1.07--1.21)                                                                     All studies                                                                           --
  Outcome self‐report diabetes or doctor diagnosis                                   1.13 (1.07--1.21)                                                                     All studies                                                                           --
  Outcome diabetes validated with blood glucose levels                               1.16 (1.13--1.18)                                                                     No studies                                                                            --
  Community population                                                               Insufficient data (only Abraham *et al*. [22](#dme13606-bib-0022){ref-type="ref"})    1.89 (1.15--3.11)                                                                     --
  Controlled for sociodemographic and cardiometabolic/adiposity                      1.16 (1.11--1.21)                                                                     1.83 (1.12--2.98)                                                                     --
  Controlled for sociodemographic, cardiometabolic/adiposity and lifestyle           1.15 (1.06--1.25)                                                                     2.21 (0.45--10.86)                                                                    --

The following studies calculated hazards ratios: Abraham *et al*. [22](#dme13606-bib-0022){ref-type="ref"}, Farvid *et al*. [27](#dme13606-bib-0027){ref-type="ref"}, Khambaty *et al*. [28](#dme13606-bib-0028){ref-type="ref"}, Pérez‐Piñar *et al*. [35](#dme13606-bib-0035){ref-type="ref"}, Scherrer *et al*. [31](#dme13606-bib-0031){ref-type="ref"} and Shirom *et al*. [37](#dme13606-bib-0037){ref-type="ref"}.

The following studies calculated odds ratios: Boyko *et al*. [23](#dme13606-bib-0023){ref-type="ref"}, Deschênes *et al*. [25](#dme13606-bib-0025){ref-type="ref"}, Edwards and Mezuk [26](#dme13606-bib-0026){ref-type="ref"}, Miller‐Archie *et al*. [30](#dme13606-bib-0030){ref-type="ref"} and Vaccarino *et al*. [32](#dme13606-bib-0032){ref-type="ref"}.

The following studies calculated risk ratios: Chien and Lin [36](#dme13606-bib-0036){ref-type="ref"} and Demmer *et al*. [24](#dme13606-bib-0024){ref-type="ref"}.

DSM‐V anxiety disorders include: Generalized anxiety disorder (GAD), panic, phobia. However, they no longer include PTSD and OCD which were classified as anxiety disorders until 2013. DSM‐IV anxiety disorders include: GAD, panic, phobia, PTSD, OCD.
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We ran a series of sensitivity analyses for the HR and OR estimates (Table [4](#dme13606-tbl-0004){ref-type="table-wrap"}). The HR estimate remained significant except when we only examined studies that had a low--moderate risk of bias. The OR estimate was reduced to non‐significance when we removed the largest study [23](#dme13606-bib-0023){ref-type="ref"}, only assessed low--moderate quality studies, and only included studies that had controlled for a variety of sociodemographic, cardiometabolic/adiposity and lifestyle factors [25](#dme13606-bib-0025){ref-type="ref"}, [26](#dme13606-bib-0026){ref-type="ref"}. We could not run sensitivity analyses for the risk ratio estimate as only two studies were included.

Discussion {#dme13606-sec-0019}
==========

The results from this systematic review and meta‐analysis indicate that anxiety symptoms and disorders (as defined by both DSM‐IV and DSM‐V criteria) are associated with an increased risk of developing incident diabetes. Furthermore, our results indicate that the association between anxiety and incident diabetes persists even after adjusting for a range of sociodemographic, cardiometabolic and adiposity‐related confounders. However, the two studies that examined the direction of association from diabetes to incident anxiety found no evidence of an association, although inferences are limited by the small number of studies and quality issues.

Anxiety to diabetes {#dme13606-sec-0020}
-------------------

Previous work has hypothesized that anxiety could lead to an increased risk of diabetes [19](#dme13606-bib-0019){ref-type="ref"}, however, to the best of our knowledge, this is the first synthesis that confirms anxiety as a risk factor for incident diabetes.

The association between anxiety and an increased risk of incident diabetes is likely due to a nuanced and complex relationship between anxiety and other risk factors for diabetes. For example, anxiety is often comorbid with other psychiatric disorders shown to be associated with diabetes risk such as depression [26](#dme13606-bib-0026){ref-type="ref"}, [38](#dme13606-bib-0038){ref-type="ref"}. Thus, it is possible that the association between anxiety and diabetes could be driven, in part, by the comorbidity of anxiety with other psychological disorders such as depression [39](#dme13606-bib-0039){ref-type="ref"}. However, where studies adjusted for depression [22](#dme13606-bib-0022){ref-type="ref"}, [26](#dme13606-bib-0026){ref-type="ref"}, [32](#dme13606-bib-0032){ref-type="ref"}, the inclusion of depression into the statistical model did not substantially affect estimates. Furthermore, anxiety is associated with some behavioural risk factors that are linked with diabetes risk factors such as unhealthy lifestyle [12](#dme13606-bib-0012){ref-type="ref"}, sleep disturbance [13](#dme13606-bib-0013){ref-type="ref"} and obesity [10](#dme13606-bib-0010){ref-type="ref"}. Anxiety is also linked with various biological changes that have been shown to increase the risk of diabetes such as inflammation [40](#dme13606-bib-0040){ref-type="ref"} and cardiometabolic abnormalities [11](#dme13606-bib-0011){ref-type="ref"}.

Although results from this analysis do not provide us with information on how anxiety is linked with an increased risk of incident diabetes, they do indicate that anxiety is an independent risk factor for diabetes even when taking confounders into account. However, more work is needed on understanding pathways of how anxiety might lead to diabetes.

Diabetes to anxiety {#dme13606-sec-0021}
-------------------

Results from this review indicate that more research is needed on the direction of association from diabetes to anxiety because only two studies were eligible for inclusion in this review. Neither study that examined diabetes as a risk factor for incident anxiety identified a significant association. Despite this, other work we identified that was not eligible for inclusion in this review did indicate a possible association. Cooper *et al*. [41](#dme13606-bib-0041){ref-type="ref"} found that young people with Type 1 diabetes (average age of 9 years at baseline) had a 2.5 times increased hazard of developing incident anxiety over 26 years. Furthermore, Huang *et al*. [38](#dme13606-bib-0038){ref-type="ref"} found a higher annual incidence of people with diabetes being diagnosed with an anxiety disorder over 5 years using data for nearly 1 million people from a Taiwanese insurance base. However, this study was not included because the lowest baseline age was 15 years. In addition, Hasan *et al*. [42](#dme13606-bib-0042){ref-type="ref"} found that diabetes was associated with a 2.6 times increased likelihood of having a current anxiety disorder after 6 years in Australian women (although they did not explicitly remove anxiety at baseline). This work indicates that there is a possibility that diabetes could lead to incident anxiety, although exclusion criteria for our study precluded the inclusion of many of these studies. Our work also indicates a need for more research to explicitly examine whether diabetes could lead to incident anxiety. Future work examining this direction of causation needs to be mindful of possible generalizability and bias issues. For example, ascertainment bias is more likely to be an issue with studies examining incident anxiety than incident diabetes as anxiety is more likely to have a diverse life course [43](#dme13606-bib-0043){ref-type="ref"}, which could limit the likelihood of capturing an event. Furthermore, as anxiety disorder tends to occur in adolescence or early adulthood [44](#dme13606-bib-0044){ref-type="ref"} the approach taken by Cooper *et al*. [41](#dme13606-bib-0041){ref-type="ref"} following people up from a younger age may better allow us to make inferences on diabetes as a cause of incident anxiety.

Clinical implications {#dme13606-sec-0022}
---------------------

This work adds to the body of evidence suggesting that poor mental health is an important diabetes risk factor. Previous work has found evidence that depression [45](#dme13606-bib-0045){ref-type="ref"}, PTSD [46](#dme13606-bib-0046){ref-type="ref"} and stress [19](#dme13606-bib-0019){ref-type="ref"} can increase a person\'s risk of developing diabetes. This is likely a complex association via various and likely interacting pathways. However, screening for and integrating treatment for mental illness into diabetes prevention programs could be important for helping to reduce the increasing prevalence of diabetes.

Despite work from this review indicating that diabetes may not be associated with an increased risk of incident anxiety, there is still evidence that anxiety is an important comorbidity to consider in people with diabetes. Anxiety is associated with poorer outcomes in people with diabetes such as poorer glycaemic control [47](#dme13606-bib-0047){ref-type="ref"}, worsened functioning [48](#dme13606-bib-0048){ref-type="ref"} and increased diabetes complications [49](#dme13606-bib-0049){ref-type="ref"}. As such, it is important for care providers to integrate the screening and treatment of mental health conditions such as anxiety into diabetes care [50](#dme13606-bib-0050){ref-type="ref"}.

Strengths and limitations {#dme13606-sec-0023}
-------------------------

There are limitations that must be acknowledged within this review. First, there were indications that publication bias may be an issue with this review and there was also notable theoretical and statistical heterogeneity evident. Therefore, results should be interpreted with caution. There were differences in anxiety assessment, diabetes assessment, populations studied and analyses conducted. However, we were mindful of this limitation in our presentation and analysis. We also only screened studies in French and English meaning there could also be language bias present. Furthermore, setting our inclusion age to 16 years meant that we had to exclude some studies that provided compelling evidence on the longitudinal relationship between anxiety and diabetes (e.g. Cooper *et al*. [41](#dme13606-bib-0041){ref-type="ref"}). In addition, there are also possibly issues with only examining anxiety 'cases'. There is a possibility that below‐threshold anxiety symptoms could also lead to an increased risk of incident diabetes, however, we were unable to determine this using data from the included studies. Therefore, future work could examine how below‐threshold anxiety symptoms are associated longitudinally with diabetes.

There are also limitations with examining both Type 1 and Type 2 diabetes when determining longitudinal associations between anxiety and diabetes. Those studies that examined anxiety as a cause of incident diabetes are more likely to capture people with Type 2 diabetes due to the earlier onset of Type 1 diabetes. However, those studies that examined diabetes as a cause of incident anxiety are arguably better conducted in people with Type 1 diabetes as they could be followed up from a younger age allowing us to better capture first cases of anxiety. It is feasible that the best way to determine causality between diabetes and anxiety would be to take a life course approach to determine the incidence of anxiety and/or diabetes while taking the date of diabetes diagnosis into account. Future work could also stratify analyses by diabetes type.

However, despite these limitations there are several strengths to the present review. To the best of our knowledge, this is the first synthesis to systematically investigate the longitudinal association between anxiety and diabetes in a large number of databases. Furthermore, we undertook a comprehensive quality assessment and heterogeneity assessments to determine the stability of estimates and potential sources of differences in results.

Conclusions {#dme13606-sec-0024}
-----------

Work from this analysis indicates that anxiety may be a risk factor for incident diabetes. However, heterogeneity between studies and evidence of publication bias suggest that results should be interpreted with caution. Furthermore, there was limited evidence that investigated the direction of association from diabetes to incident anxiety indicating the need for future work to investigate this direction of causality.
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